NGS for Personalized Medicine
In the context of the kick-off meeting of the H2020 pre-commercial procurement project Instand-NGS4P (Integrated and standardized NGS workflows for personalised therapy) that is coordinated by Med Uni Graz, we are pleased to announce a public workshop that will provide background information on this 4.5 year project, and feature presentations on the current scientific and medical research work of the project partners.
Instand-NGS4P is a pre-commercial procurement (PCP) project, inviting commercial diagnostics providers to develop these workflows. Focusing on patient requirements and medical needs it will result in two fully integrated, standardized next-generation sequencing (NGS) workflows for routine diagnostics of common and rare juvenile and adult cancers. It joins seven leading medical centres having major experience in using different NGS platforms in research and routine diagnostics together with European patient advocacy groups, a standardization organization and partners participating in the European infrastructures BBMRI-ERIC, ELIXIR as well as several NGS-related EU programs to cover all technical aspects and transversal needs and requirements. The modular design of the workflows will particularly enable SMEs to contribute, and provides flexibility to adopt emerging user needs and technologies. Specifications will address regulatory requirements for In-Vitro Diagnostics with reference to international standards, and will require development of reference materials and implementation of external quality assessment schemes covering the whole workflow. R&D suppliers will be selected based on a public tender in the course of this PCP process.